Literature DB >> 11585076

Community and nosocomially acquired respiratory syncytial virus infection in a German paediatric hospital from 1988 to 1999.

R Berner1, F Schwoerer, R F Schumacher, M Meder, J Forster.   

Abstract

UNLABELLED: Respiratory syncytial virus (RSV) is the major cause of lower respiratory tract infections in infants. Since epidemiological data from Germany are scarce, a large retrospective hospital based analysis was performed. In the first part of the study, laboratory records were checked for RSV positive specimens from January 1988 to December 1997. A total of 1664 specimens were positive corresponding to 1171 episodes in 1064 patients; 88% were up to 4 years old and 47% up to 3 months old. The percentage of premature newborns from all patients 0-4 years old was 24%. The rate of nosocomial infection was 38%. The core RSV season began in December, lasted until April, and peaked in January and February. In the second part of the study, from April 1, 1997 to March 31, 1999, which encompassed two RSV winter seasons, patients with the ICD-9 coded discharge diagnoses of lower respiratory tract infections, bronchopulmonary dysplasia (BPD) and prematurity were analysed. Of the premature newborns, 25% were tested RSV positive at least once up to the age of 1 year, as were 52% of those with BPD. The rehospitalisation rate due to RSV infection was 22% in patients with BPD, and 8.9% in all premature newborns. Of patients with community acquired RSV infection, 12% required intensive care and 6% had to be ventilated mechanically. The mortality rates in both parts of the study were 0.8% and 0.7%, respectively.
CONCLUSION: Respiratory syncytial virus infection in young children is also of major importance in Germany. Although the mortality rate is low, the high incidence and the severity of the disease in the particular risk group of premature infants with chronic lung disease contribute to a very high disease burden.

Entities:  

Mesh:

Year:  2001        PMID: 11585076     DOI: 10.1007/s004310100801

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  12 in total

1.  Preventing hospitalizations for respiratory syncytial virus infection.

Authors:  Joan L Robinson; Nicole Le Saux
Journal:  Paediatr Child Health       Date:  2015 Aug-Sep       Impact factor: 2.253

2.  A comparative study of respiratory syncytial virus (RSV) prophylaxis in premature infants within the Canadian Registry of Palivizumab (CARESS).

Authors:  B Paes; I Mitchell; A Li; K L Lanctôt
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-05-01       Impact factor: 3.267

3.  Clinical findings and unusual epidemiologic characteristics of human metapneumovirus infections in children in the region of Basel, Switzerland.

Authors:  Gurli Baer; Urs B Schaad; Ulrich Heininger
Journal:  Eur J Pediatr       Date:  2007-02-13       Impact factor: 3.183

4.  Epidemiology of respiratory syncytial virus in children ≤2 years of age hospitalized with lower respiratory tract infections in the Russian Federation: a prospective, multicenter study.

Authors:  Vladimir Tatochenko; Vasily Uchaikin; Aleksandr Gorelov; Konstantin Gudkov; Andrew Campbell; Gregory Schulz; Rebecca Prahl; Gerard Notario
Journal:  Clin Epidemiol       Date:  2010-10-21       Impact factor: 4.790

5.  Genetic variability of group A human respiratory syncytial virus strains circulating in Germany from 1998 to 2007.

Authors:  Janine Reiche; Brunhilde Schweiger
Journal:  J Clin Microbiol       Date:  2009-04-22       Impact factor: 5.948

6.  Prospective population-based study of viral lower respiratory tract infections in children under 3 years of age (the PRI.DE study).

Authors:  Johannes Forster; Gabriele Ihorst; Christian H L Rieger; Volker Stephan; Hans-Dieter Frank; Heidrum Gurth; Reinhard Berner; Angela Rohwedder; Hermann Werchau; Martin Schumacher; Theodore Tsai; Gudula Petersen
Journal:  Eur J Pediatr       Date:  2004-12       Impact factor: 3.183

7.  Respiratory syncytial virus detection by Remel Xpect, Binax Now RSV, direct immunofluorescent staining, and tissue culture.

Authors:  Anita P Borek; Susan H Clemens; Valerie K Gaskins; Deborah Z Aird; Alexandra Valsamakis
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

8.  Bacteraemia and antibiotic use in respiratory syncytial virus infections.

Authors:  P Bloomfield; D Dalton; A Karleka; A Kesson; G Duncan; D Isaacs
Journal:  Arch Dis Child       Date:  2004-04       Impact factor: 3.791

9.  Defining the timing of respiratory syncytial virus (RSV) outbreaks: an epidemiological study.

Authors:  Elena Terletskaia-Ladwig; Gisela Enders; Gunnar Schalasta; Martin Enders
Journal:  BMC Infect Dis       Date:  2005-03-31       Impact factor: 3.090

10.  Does the viral subtype influence the biennial cycle of respiratory syncytial virus?

Authors:  Gordana Mlinaric-Galinovic; Gordana Vojnovic; Jasna Cepin-Bogovic; Ana Bace; Jadranka Bozikov; Robert C Welliver; Ulrich Wahn; Ljiljana Cebalo
Journal:  Virol J       Date:  2009-09-07       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.